Mentor Capital Moves Up to Fully Reporting with Initial Form 10
The Form 10 is the first of the 10K, 10Q family of ongoing reports that will now begin to be regularly filed by Mentor Capital with the SEC. Like with any of these reports, the Form 10 is subject to comment by the SEC staff. As the comments, if any, are being resolved, Mentor Capital, Inc. will apply to the OTC Markets Group to move up to being reported on their OTCQB system, according to the company.
The Form 10 which includes 2012 and 2013 audited financials, together with reviewed financials for the first nine months of 2014 can be referenced through the SEC’s EDGAR system at:
Inputting the company name, Mentor Capital, Inc. or the company’s CIK code which is 0001599117, will bring up the report. The Form 10 can also be viewed at the company’s web site at the Investor’s Corner section under the Disclosures tab, that is at:
Mentor Capital intends to release a discussion on its reported third quarter financial results, November 21, 2014.
About Mentor Capital: By acquisition or stock purchase, Mentor Capital, Inc. seeks to invest in leading cannabis companies. Additional important information for investors and founders seeking expansion funding is presented at:www.MentorCapital.com
This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.
Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” or “intends,” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales activities, problems securing the necessary financing to continue operations, problems encountered in commercializing cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, difficulties in recruiting knowledgeable personnel and potential problems in protecting intellectual property. Further information concerning these and other risks is included in the Company’s Form 10 filing which, along with other very important information about the Company, can be found here:
The Company undertakes no obligation to update or revise such forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Chet Billingsley, CEO